Robey R - Search Results

1

Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family.

Bishop PC, Myers T, Robey R, Fry DW, Liu ET, Blagosklonny MV, Bates SE. Bishop PC, et al. Among authors: robey r. Oncogene. 2002 Jan 3;21(1):119-27. doi: 10.1038/sj.onc.1205028. Oncogene. 2002. PMID: 11791182

2

Chemoresistance in the clinic: overview 1994.

Bates SE, Regis JI, Robey RW, Zhan Z, Scala S, Meadows BJ. Bates SE, et al. Among authors: robey rw. Bull Cancer. 1994 Dec;81 Suppl 2:55s-61s. Bull Cancer. 1994. PMID: 7727860 Review.

3

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE. Wosikowski K, et al. Among authors: robey rw. Cell Growth Differ. 1995 Nov;6(11):1395-403. Cell Growth Differ. 1995. PMID: 8562478

4

Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.

Gudas JM, Nguyen H, Li T, Sadzewicz L, Robey R, Wosikowski K, Cowan KH. Gudas JM, et al. Among authors: robey r. Carcinogenesis. 1996 Jul;17(7):1417-27. doi: 10.1093/carcin/17.7.1417. Carcinogenesis. 1996. PMID: 8706243

5

Clinical reversal of multidrug resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Among authors: robey r. Stem Cells. 1996 Jan;14(1):56-63. doi: 10.1002/stem.140056. Stem Cells. 1996. PMID: 8820952 Review.

6

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.

Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE. Lee JS, et al. Among authors: robey r. J Cell Biochem. 1997 Jun 15;65(4):513-26. J Cell Biochem. 1997. PMID: 9178101

7

Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles.

Alvarez M, Robey R, Sandor V, Nishiyama K, Matsumoto Y, Paull K, Bates S, Fojo T. Alvarez M, et al. Among authors: robey r. Mol Pharmacol. 1998 Nov;54(5):802-14. doi: 10.1124/mol.54.5.802. Mol Pharmacol. 1998. PMID: 9804615

8

Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833.

Robey R, Bakke S, Stein W, Meadows B, Litman T, Patil S, Smith T, Fojo T, Bates S. Robey R, et al. Blood. 1999 Jan 1;93(1):306-14. Blood. 1999. PMID: 9864175 Free article. Clinical Trial.

9

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE. Miyake K, et al. Among authors: robey r. Cancer Res. 1999 Jan 1;59(1):8-13. Cancer Res. 1999. PMID: 9892175

10

Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, Robey R, Pommier Y, Fojo T, Bates SE. Brangi M, et al. Among authors: robey r. Cancer Res. 1999 Dec 1;59(23):5938-46. Cancer Res. 1999. PMID: 10606239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters